RECRUITINGOBSERVATIONAL
In-depth Immunological Investigation of COVID-19.
In-depth Characterisation of the Dynamic Host Immune Response to Coronavirus SARS-CoV-2
About This Trial
The COntAGIouS trial (COvid-19 Advanced Genetic and Immunologic Sampling; an in-depth characterization of the dynamic host immune response to coronavirus SARS-CoV-2) proposes a transdisciplinary approach to identify host factors resulting in hyper-susceptibility to SARS-CoV-2 infection, which is urgently needed for directed medical interventions.
Who May Be Eligible (Plain English)
Who May Qualify:
- Patients \>/= 18 years old AND
- Hospitalised with PCR-confirmed and/or CT-confirmed SARS-CoV-2 disease
Who Should NOT Join This Trial:
- Age \< 18 years old
- No willing to sign a consent form
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Patients \>/= 18 years old AND
* Hospitalised with PCR-confirmed and/or CT-confirmed SARS-CoV-2 disease
Exclusion Criteria:
* Age \< 18 years old
* No informed consent
Treatments Being Tested
OTHER
Patient sampling
Blood draw, NP/rectal swab, bronchoscopy if clinically indicated, lung tissue if applicable
Locations (1)
UZ Leuven
Leuven, Belgium